Wake Forest University Health Sciences: Glioma trials

The registry lists 12 Glioma studies with Wake Forest University Health Sciences as lead sponsor. 1 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 1Phase 2 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• MRI in High-Grade Glioma Patients Undergoing ChemoradiationRecruitingNCT05212272Not applicable
• Solriamfetol in Improving Sleep in Patients With Grade II-IV GliomaTerminatedNCT03868943Phase 2Results posted
• A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade GliomasCompletedNCT01188096Phase 2Results posted
• Cereset for CaregiversWithdrawnNCT03935269Not applicable
• Social Determinants of Health in Glioblastoma PopulationCompletedNCT03900689
• Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain MetastasesTerminatedNCT03796273Early Phase 1
• Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain TumorsCompletedNCT02747407
• Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation TherapyTerminatedNCT02375334
• Glioma Modified Atkins-based Diet in Patients With GlioblastomaCompletedNCT02286167Not applicable
• Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable
• Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaTerminatedNCT01103375Phase 1
• Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT00079092Phase 2